JPMorgan analyst David Adlington raised the firm’s price target on Fresenius Medical to EUR 35.40 from EUR 33 and keeps an Underweight rating on the shares.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
See the top stocks recommended by analysts >>
Read More on FMS:
- A New Cause for Concern: Fresenius Medical Care Adds a New International Operations Risk
- Fresenius Medical Care delivers on commitments in a year of fundamental transformation
- Fresenius Medical price target raised to EUR 33 from EUR 28 at JPMorgan
- Fresenius Medical reinstated with an Underperform at BofA
- Fresenius Medical downgraded to Underweight from Equal Weight at Morgan Stanley
